Claudia Graham joined Dexcom as its VP of Marketing in September 2008 and led the successful launches of the Seven Plus and the G4 PLATINUM CGM systems. Globally recognized as a thought leader in access to diabetes technologies, Claudia became VP of Global Access in early 2013, and is responsible for strategic reimbursement, health economics, government relations and advocacy – focused on improving access to CGM for patients and physicians both domestically and internationally.
She received her PhD from the University of Southern California and her MPH from the University of California, Los Angeles. Prior to Dexcom, she was Vice President of Marketing & Product Development at MiniMed, and subsequently served as Vice President of Global Access Therapy at Medtronic. Before her work began in the medical device sector, she was a Director of Marketing for Warner Lambert. She has served on various national and local advisory boards serving the medical community including the national board of the Medical Marketing Association of America, the community board of directors for the Northridge Hospital Medical Center and the San Diego and Los Angeles chapters of the JDRF. She has been professionally active in the diabetes community for many years, having presented and published articles at scientific conferences of the ADA, EASD, etc.